Hepcinat Plus Tablets: Uses, Side Effects & Product Details

Hepcinat Plus Tablets are an antiviral medicine used in the treatment of chronic hepatitis C virus (HCV) infection. The commonly listed formulation contains sofosbuvir 400 mg and daclatasvir 60 mg per tablet. These direct-acting antiviral medicines target different proteins involved in hepatitis C virus replication.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and supply-related assistance for international markets, subject to applicable export regulations, product availability and destination-country requirements.

Hepcinat Plus is a prescription medicine. Its suitability depends on the patient's clinical condition, hepatitis C genotype, liver health, previous treatment history and potential drug interactions.

Uses of Hepcinat Plus Tablets

Hepcinat Plus is used under medical supervision for the treatment of chronic hepatitis C infection when the combination is appropriate for the patient.

The active ingredients work in complementary ways:

Sofosbuvir 400 mg: Inhibits a viral enzyme required for copying hepatitis C genetic material.

Daclatasvir 60 mg: Targets the HCV NS5A protein, which plays an important role in viral replication.

Treatment aims to achieve a sustained virological response, meaning the virus remains undetectable after treatment according to the recommended testing schedule. The appropriate regimen and duration must be determined by a qualified healthcare professional.

Benefits and Important Considerations

When prescribed for an appropriate patient, antiviral treatment can help eliminate hepatitis C infection and reduce the risk of future liver complications.

However, Hepcinat Plus is not suitable for everyone, and treatment outcomes depend on individual medical factors. Patients should undergo appropriate assessment and follow-up testing. Previous hepatitis B infection is particularly important to disclose because hepatitis B reactivation can occur during direct-acting antiviral treatment.

Possible Side Effects of Hepcinat Plus

Some patients may experience side effects, including:

Headache

Fatigue or tiredness

Nausea

Diarrhoea

Difficulty sleeping

These effects may vary between individuals. Contact a healthcare professional if symptoms persist or worsen. Seek urgent medical attention for severe allergic reactions, fainting, chest pain or breathing difficulties.

Sofosbuvir-containing regimens can also cause serious bradycardia (an unusually slow heartbeat) when used with amiodarone. Inform your doctor about all medicines, supplements and herbal products you take before starting treatment.

Frequently Asked Questions (FAQs)

1. What is Hepcinat Plus used for?

Hepcinat Plus is an antiviral medicine used to treat chronic hepatitis C infection in appropriately selected patients under medical supervision.

2. What are the ingredients in Hepcinat Plus Tablets?

The commonly listed strength contains sofosbuvir 400 mg and daclatasvir 60 mg per tablet. Always verify the product label and approved product documentation.

3. What are the common side effects?

Headache, fatigue, nausea and diarrhoea are among the reported side effects. Consult a healthcare professional for persistent or severe symptoms.

4. Can I take Hepcinat Plus without a prescription?

No. Do not start, stop or change antiviral treatment without guidance from a qualified healthcare professional.

5. How can international buyers enquire about Hepcinat Plus?

International pharmaceutical buyers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product documentation, availability, applicable export requirements and destination-market regulatory compliance. Supply is subject to verification and applicable laws.

Contact Cordium Pharmaceuticals Pvt Ltd

For product information and pharmaceutical supply enquiries regarding Hepcinat Plus Tablets, contact Cordium Pharmaceuticals Pvt Ltd through your company's verified business contact channels.

Medical disclaimer: This content is for general educational and product-information purposes only. It is not a substitute for medical advice, diagnosis or treatment. Product registration, approved indications and availability may vary by country. Verify current product details and regulatory status before publication or supply.